openPR Logo
Press release

Frontotemporal Disorders Treatment Market | Cost Structure Analysis and Forecast to 2032 - By FMI

12-10-2022 01:08 AM CET | Health & Medicine

Press release from: Future Market Insights

Frontotemporal Disorders Treatment Market | Cost Structure

According to the latest research by the company, the global Frontotemporal Disorders Treatment Market is expected to be valued at US$ 451.4 Mn, by 2028 end. The report on the frontotemporal disorders treatment market projects major growth potential with average year-on-year growth rate of 4.7% through 2028.

Request a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5033

The increasing funding by the governments across the globe for R&D is projected to be the major factor expected to propel the growth of the frontotemporal disorders treatment market over the forecast period. Government organizations such as the National Institute of Aging (NIA), National Institute of Neurological Disorders and Strokes (NINDS) and National Institute of Health (NIH) are conducting research and development support programs and making efforts to advance therapeutic development in neurological diseases.

The growing number of dementia cases has increased the population base of frontotemporal dementia, which is expected to propel the demand for frontotemporal dementia drugs and medications. Rising life expectancy rate is another major factor expected to boost the growth of the frontotemporal disorders treatment market.

Increasing funding and grants by the various non-profit organizations for drug development is also expected to boost the growth of the frontotemporal disorders treatment market.

Research funding initiatives by non-profit organization such as the Association for Frontotemporal Degeneration (AFTD), Alzheimer Discovery Foundation (ADDF), Bluefield Project Organization, Tau Consortium Organization, CurePSP, Inc. have helped to promote FTD research initiatives.

However, lack of approved drugs for frontotemporal disorder treatment is expected to negatively impact the growth of the frontotemporal disorders treatment market. Moreover, the high failure rate of clinical trials and studies is also a major factor expected to hamper the growth of the frontotemporal disorders treatment market.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5033

The company has segmented the global frontotemporal disorders treatment market based on drug class, treatment type, disease indication, distribution channel, and regions. Based on drug class, the frontotemporal disorders treatment market is segmented into cognitive enhancers, antipsychotics, antidepressants, CNS stimulants, and others. The cognitive enhancers segment is expected to contribute high revenue share in global frontotemporal disorders treatment market.

By treatment type, the frontotemporal disorders treatment market is segmented into behavioral symptom management and psychological symptoms management segment.

The behavioral symptom management segment is expected to contribute high value share in the global frontotemporal disorders treatment market. Based on disease indication, the frontotemporal disorders treatment market is segmented into frontotemporal dementia, primary progressive aphasia, and movement disorders segment.

In terms of revenue, the frontotemporal dementia segment is projected to hold significant share in the global frontotemporal disorders treatment market over the forecast period. Based on distribution channels, the frontotemporal disorders treatment market is segmented into hospital pharmacies, retail pharmacy, drug stores, and online pharmacy. The retail pharmacy segment is expected to contribute high value share in the global frontotemporal disorders treatment market.

On the basis of region, the global frontotemporal disorders treatment market has been segmented into North America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Latin America and the Middle East & Africa. Western Europe is expected to contribute large revenue share in the global frontotemporal disorders treatment market over the forecast period. The demand for frontotemporal disorders treatment has increased in Western Europe due to the increasing prevalence of frontotemporal dementia as well as growing number of clinical studies in the region. North America is expected to contribute second large revenue share in the global frontotemporal disorders treatment market.

The Asia Pacific Excluding Japan (APEJ) is projected to witness significant growth due to increasing per capita expenditure and government initiatives for the treatment of neurological disorders.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-5033

The report tracks some of the key manufacturers operating in the global frontotemporal disorders treatment market. The players included in the report are Pfizer Inc., Johnson & Johnson, Sanofi S.A., Eli Lilly and Company, GlaxoSmithKline Plc., Novartis AG, Mylan N.V., Merck & Company, Inc., AstraZeneca plc, and Allergen plc, among others.

Contact:
Future Market Insights, Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware

About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Frontotemporal Disorders Treatment Market | Cost Structure Analysis and Forecast to 2032 - By FMI here

News-ID: 2843121 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for Frontotemporal

Frontotemporal Dementia (FTD) Market to Reach USD 4.3 Billion by 2034
Frontotemporal Dementia (FTD) is a rare yet serious group of neurodegenerative disorders characterized by progressive damage to the frontal and temporal lobes of the brain. Unlike Alzheimer's disease, FTD often manifests earlier in life, typically between the ages of 40 and 65, and is marked by personality changes, impaired judgment, and language difficulties. Its early onset and challenging diagnosis make it one of the most complex forms of dementia to
Frontotemporal Dementia Market Set to Double by 2034, Reaching USD 4.2 Billion
The global FTD market was valued at USD 2.1 billion in 2024 and is projected to reach USD 4.2 billion by 2034, growing at a CAGR of 7.1%. Rising diagnosis rates, growing investment in neurodegenerative disease research, and expanded healthcare access are driving this growth. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70788 Key Market Highlights • Increasing recognition of FTD as distinct from Alzheimer's and other dementias. • Expanding pipeline of clinical trials
Frontotemporal Dementia Treatment Market - Empathy in Action: Pioneering Frontot …
Newark, New Castle, USA: The "Frontotemporal Dementia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Frontotemporal Dementia Treatment Market: https://www.growthplusreports.com/report/frontotemporal-dementia-treatment-market/8569 This latest report researches the industry structure,
Frontotemporal Dementia Treatment Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Frontotemporal Dementia Treatment Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies
Frontotemporal Disorder Treatment Market Size, Share, Impressive Industry Growth …
The global Frontotemporal Disorder treatment market is anticipated to showcase considerable growth during the forecast period (2020-2026). The rising orphan drug development initiatives by the FDA, new product launches and the growing geriatric population are some of the key factors contributing to the growth of the global Frontotemporal Disorder treatment market. According to the World Health Organization, in 2019 around 50 million people are living with dementia and the number
Improvement In Cognitive Empathy to Drive The Frontotemporal Dementia Treatment …
The global Frontotemporal Dementia Treatment Market is bound to witness a CAGR worth satiating In Upcoming Years. In the era of cloud computing, the cloud revolution is there to break the stereotypes. Several key stakeholders are going for cloud hosting solutions providers to enhance their accounting services. This migration to cloud technology is making way for the enterprises to simplify their daily tasks, that too, conveniently and cost-effectively. As such,